In this issue:
- Screening for colorectal cancer
- Multitarget faecal immunochemical test for colorectal cancer screening
- HRQoL with pembrolizumab vs chemotherapy
- Regorafenib + avelumab for microsatellite stable colorectal cancer
- PD-L1 and CTLA-4 inhibition with targeted low-dose or hypofractionated radiation
- COVID-19 impact on colorectal cancer diagnosis and management
- Circulating tumour DNA dynamics and recurrence risk
- Sorafenib + capecitabine for metastatic colorectal cancer
- Impact of IDEA collaboration study results on French clinical practice
- Impact of geography on prognostic outcomes in clinical trials
Please login below to download this issue (PDF)